Cobas H 232 POC System - Roche Diagnostics

You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode. close

User Profile

close navigation Change

Select your user profile

close navigation

• healthcare Healthcare Professionals
• researcher Researchers
• patient General Audiences

For in vitro diagnostic use. Instrument cobas h 232 IVD cobas® h 232 POC system INS_653 04901126060 cobas h 232 Kit (no scanner) (NO) cobas h 232 07613336205686 Meters Not Available Not Available 04901126190 cobas h 232 Kit (no scanner) cobas h 232 04015630052660 Meters Not Available Not Available 04901126057 cobas h 232 Kit (no scanner) (FI SV) cobas h 232 07613336205679 Meters Not Available Not Available 04901126053 cobas h 232 Kit (no scanner) (IS GR) cobas h 232 07613336205723 Meters Not Available Not Available 04901126005 cobas h 232 Kit (no scanner) (DE FR NL) cobas h 232 07613336205648 Meters Not Available Not Available 04901126051 cobas h 232 Kit (no scanner) (SK) cobas h 232 07613336205716 Meters Not Available Not Available 04901126026 cobas h 232 Kit (no scanner) (DA ) cobas h 232 07613336205624 Meters Not Available Not Available 04901126134 cobas h 232 Kit (no scanner) (PL BG) cobas h 232 07613336205693 Meters Not Available Not Available 04901126016 cobas h 232 Kit (no scanner) (DE FR IT) cobas h 232 07613336205631 Meters Not Available Not Available 04901126039 cobas h 232 Kit (no scanner) (RO) cobas h 232 07613336205709 Meters Not Available Not Available 04901126045 cobas h 232 Kit (no scanner) (EE LT LV) cobas h 232 07613336205655 Meters Not Available Not Available 04901126037 cobas h 232 Kit (no scanner) (ES PT) cobas h 232 07613336205662 Meters Not Available Not Available 04901126041 cobas h 232 Kit (no scanner) (CZ) cobas h 232 07613336205617 Meters Not Available Not Available The cobas h 232 is an in vitro diagnostic instrument intended for the quantitative evaluation of immunoassays using the Roche CARDIAC test strips in human whole blood. The cobas h 232 is intended for near-patient testing. Not for self-testing. en Fully portable, and maintenance-free hand-held device that enables intuitive handling via its icon-based ​user guidance, allowing tests to be run in three simple steps.​​Warm-up of test strips is integrated in the testing process, thereby reducing waiting time.Ca​n be moved during testing​​Troponin T and NT-proBNP offer consistent and comparable results among different platforms and provide increased reliability compared to Troponin I and BNP​Roche POC Troponin T can be used to rule in patients with suspected AMI at high risk of mortality with evidence based cut-off, aligned with Elecsys® high sensitive Troponin T​NT-proBNP is the biomarker of choice for the patients under Entresto treatment​POC and laboratory results and cut-offs can easily be compared across different settings - pre-hospitals, ED, laboratories en

1. Products
2. cobas® h 232 POC system

cobas® h 232 POC system On the spot results to support efficient diagnosis and management of cardiovascular diseases IVD For in vitro diagnostic use.

On-the-spot care and share

The cobas h 232 POC system is a portable point-of-care system to support optimized diagnostics and treatment of patients with cardiovascular disease. Designed for healthcare providers, it delivers objective results that are aligned with the Roche laboratory methods and can be shared wirelessly for immediate feedback and response.

Fast

On-the-spot results are available in 12 minutes or less1,2,3,4,5

Portable

Handheld point of care system is lightweight and easy to use, even in mobile situation6

Confident

Accurate results, aligned with Roche central laboratory tests7

Governance

Connection to the cobas® infinity POC solution helps remote management of the POC testing and quality assurance from a single location.6

Available tests

View Full Table close

Available tests

The cobas h 232 POC system allows rapid and easy determination of Troponin T, NT-proBNP, D-Dimer, CK-MB and Myoglobin in different settings, like ambulances, general practitioner offices and emergency rooms.

The cobas h 232 POC system allows rapid and easy determination of Troponin T, NT-proBNP, D-Dimer, CK-MB and Myoglobin in different settings, like ambulances, general practitioner offices and emergency rooms.

Test	Measuring range	Time to result	Clinical utility
Troponin T	40 –  2,000 ng/L	12 min	Early aid in diagnosis of acute myocardial infarction and identification of patients with an elevated mortality risk1
NT‑proBNP	60 –  9,000 pg/mL	12 min	Aid in diagnosis of patients with suspected heart failure, in monitoring of patients with compensated left ventricular dysfunction and in the risk stratification of patients with acute coronary syndromes2 Help in the CV risk assessment of patients with T2D. Aid in the identification of patients at CV risk with T2D without known history of CV disease to optimize cardioprotective treatment Can be used to identify elderly individuals at high‐risk for atrial fibrillation2
D-Dimer	0.1 - 4.0 µg/mL	8 min	Aid in exclusion of deep venous thrombosis and pulmonary embolism3
CK-MB	1.0 – 40 ng/mL	12 min	Aid in diagnosis of patients with suspected AMI, assessment of the size of the infarction and detection of re-infarction4
Myoglobin	30 – 700 ng/mL	8 min	Aid in diagnosis of patients with suspected myocardial infarction, reperfusion control5

AMI: Acute Myocardial Infarction; NT-proBNP: N-terminal pro b-type natriuretic peptides; POC: Point of Care; CV: Cardiovascular; T2D: Type 2 diabetes

Management of heart failure (HF) in the primary care settings

NT-proBNP helps to early detect Type 2 Diabetes (T2D) patients at high risk of HF, regardless of previous history of cardiovascular disease.8

• Type 2 Diabetes patients are at increased risk of cardiovascular disease.8
• NT-proBNP value > 125 pg/mL helps identify T2D patients in need of intensified care and improve HF outcomes.8,9
• NT-proBNP POC testing is practical and can be pragmatically targeted for screening people with T2D in routine clinical practice.10

NT-proBNP on cobas h 232 supports the initial diagnosis of HF and the monitoring of the disease progression in out-patient settings.2,11,12

The story of Paul and the management of his chronic heart failure playicon playicon videoCtrl / fullScreen Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

NT-proBNP testing on the cobas h 232 POC system supports rapid up-titration as shown in the STRONG-HF study13

• Patients admitted for acute HF can be rapidly and safely up-titrated to recommended doses of guideline-directed medical therapy by following the strategy that includes NT-proBNP.
• HCPs, patients and their families can benefit from an improvement in post-discharge management leading to reductions of the re-hospitalization and mortality and enhanced patient quality of life.

Enabling faster triaging decisions for patients with suspected acute myocardial infarction in pre-hospital setting and emergency room

Pre-hospital measurement of POC Troponin T allows early identification of patients at high risk of mortality and helps ensure a fast triage to the correct location.14, 15

Related information

• STRONG-HF: the biomarker-led post-acute heart failure treatment strategy you have been waiting for

Contact Roche

Contact a Roche representative. Do you have questions about our products or services? We're here to help! Contact us today.

Form Successfully Submitted! Thank you for your submission! text close Contact us

Pre-hospital measurement of POC Troponin T in low-risk suspected NSTE-ACS patients can help save healthcare costs by reducing emergency department visits.16

 

POC Troponin T: Roche Cardiac POC Troponin T on cobas h 232, NSTE-ACS: non-ST-segment elevation acute coronary syndrome

You might be interested in

... ...

References

1. Roche Cardiac POC Troponin T Method Sheet V 3.0 (2019).
2. Roche Cardiac NT-proBNP Method Sheet V 2.0 (2024).
3. Roche Cardiac D-Dimer Method Sheet V 6.0 (2023).
4. Roche Cardiac CK-MB Method Sheet V 5.0 (2018).
5. Roche Cardiac M Method Sheet V 7.0 (2018).
6. Roche cobas h 232 POC system Operator's Manual V 7.0 (2022).
7. Bertsch T et al. (2010). Clin Lab 56(1-2): 37-49.
8. Huelsmann M et al. (2008). Eur Heart J 29(18): 2259-2264.
9. Huelsmann M et al. (2013). J Am Coll Cardiol 62(15): 1365-1372.
10. Ceriello A et al. (2023). J Diabetes Complications 37(3):108410.
11. McDonagh TA et al. (2021). Eur Heart J 42(36): 3599-3726.
12. Taylor CJ et al. (2017). Br J Gen Pract 67(660): 326-327.
13. Mebazaa A et al. (2022). Lancet 400(10367): 1938-1952.
14. Stengaard C et al. (2013). Am J Cardil 112(9): 1361-1366.
15. Rasmussen MB et al. (2017). Eur Heart J 39(1): 5-6.
16. Camaro J et al. (2023). Eur Heart J 44(19):1705-1714.

• Product Information
• Ordering Information
• Product Description
• Assay Menu
• Documents

Contact us

Overview

Ordering Information

close search Back

Technical Documents

Access important product documentation including relevant certificates and other resources.

After clicking below, you will be redirected to eLabDoc, where you can select your local country-specific documents. Document repository Sorry, we couldn't find the content you are looking for Please try again later

Related Products

... ...

Modal Title

Some randomr randomr randomr randomr randomr randomr Close Save changes